The spectrum of intermediate syndrome following acute organophosphate poisoning: A prospective cohort study from Sri Lanka

PLoS Medicine

Volumn 5, Issue 7, 2008, Pages 1143-1153

  Jayawardane, Pradeepa ^a,b   Dawson, Andrew H ^a,c   Weerasinghe, Vajira ^a   Karalliedde, Lakshman ^a,d,e   Buckley, Nicholas A ^a,f   Senanayake, Nimal ^a  

^a UNIVERSITY OF PERADENIYA   (Sri Lanka)

^b UNIVERSITY OF SRI JAYEWARDENEPURA   (Sri Lanka)

^c UNIVERSITY OF NEWCASTLE   (Australia)

^d KING'S COLLEGE LONDON   (United Kingdom)

^e PUBLIC HEALTH ENGLAND   (United Kingdom)

^f AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ATROPINE; ORGANOPHOSPHATE; PRALIDOXIME; NEUROMUSCULAR BLOCKING AGENT; PESTICIDE;

ADULT; ARTICLE; FEMALE; HUMAN; INTERMEDIATE SYNDROME; INTOXICATION; MAJOR CLINICAL STUDY; MALE; MEDIAN NERVE; MUSCLE WEAKNESS; NERVE STIMULATION; PARALYSIS; RESPIRATORY FAILURE; SRI LANKA; ULNAR NERVE; CHEMICALLY INDUCED DISORDER; COHORT ANALYSIS; NEUROMUSCULAR JUNCTION DISORDER; ORGANOPHOSPHATE POISONING; PATHOLOGY; PROSPECTIVE STUDY; SYNDROME;

COHORT STUDIES; FEMALE; HUMANS; MALE; MUSCLE WEAKNESS; NEUROMUSCULAR JUNCTION DISEASES; NEUROMUSCULAR NONDEPOLARIZING AGENTS; ORGANOPHOSPHATE POISONING; PESTICIDES; PROSPECTIVE STUDIES; RESPIRATORY INSUFFICIENCY; SRI LANKA; SYNDROME;

EID: 48749125321     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/journal.pmed.0050147     Document Type: Article

References (47)

1. Karalliedde L, Senanayake N (1988) Acute organophosphorus insecticide poisoning in Sri Lanka. Forensic Sci Int 36: 97-100.
2. Langley R, Sumner D (2002) Pesticide mortality in the United States 1979-1998. Vet Hum Toxicol 44: 101-105.
3. Buckley NA, Roberts D, Eddleston M (2004) Overcoming apathy in research on organophosphate poisoning. BMJ 329: 1231-1233.
4. Buckley NA, Karalliedde L, Dawson A, Senanayake N, Eddleston M (2004) Where is the evidence for treatments used in pesticide poisoning? Is clinical toxicology fiddling while the developing world burns? J Toxicol Clin Toxicol 42: 113-116.
5. Senanayake N, Karalliedde L (1987) Neurotoxic effects of organophosphorus insecticides. An intermediate syndrome. N Engl J Med 316: 761-763.
6. Eddleston M, Mohamed F, Davies JO, Eyer P, Worek F, et al. (2006) Respiratory failure in acute organophosphorus pesticide self-poisoning. QJM 99: 513-522.
7. He F, Xu H, Qin F, Xu L, Huang J, et al. (1998) Intermediate myasthenia syndrome following acute organophosphates poisoning-an analysis of 21 cases. Hum Exp Toxicol 17: 40-45.
8. Avasthi G, Singh G (2000) Serial neuro-electrophysiological studies in acute organophosphate poisoning:correlation with clinical findings, serum cholinesterase levels and atropine dosages. J Assoc Physicians India 48: 794-799.
9. Sedgwick EM, Senanayake N (1997) Pathophysiology of the intermediate syndrome of organophosphorus poisoning. J Neurol Neurosurg Psychiatry 62: 201-202.
10. Karalliedde L, Henry JA (1993) Effects of organophosphates on skeletal muscle. Hum Exp Toxicol 12: 289-296.
11. De Bleecker J, Van den Neucker K, Colardyn F (1993) Intermediate syndrome in organophosphorus poisoning: a prospective study. Crit Care Med 21: 1706-1711.
12. Benson B, Tolo D, McIntire M (1992) Is intermediate syndrome in organophosphate poisoning the result of insufficient oxime therapy? J Toxicol Clin Toxicol 30: 347-349.
13. John M, Oommen A, Zachariah A (2003) Muscle injury in organophosphorous poisoning and its role in the development of intermediate syndrome. Neurotoxicology 24: 43-53.
14. Dandapani M, Zachariah A, Kavitha MR, Jeyaseelan L, Oommen A (2003) Oxidative damage in intermediate syndrome of acute organophosphorous poisoning. Indian J Med Res 117: 253-259.
15. Katz EJ, Cortes IV, Eldefrawi EM, Eldefrawi AT (1997) Chlorpyrifos, parathion, and their oxons bind to and desensitize a nicotinic acetylecholine receptor: relevance to their toxicities. Toxicol Appl Pharmacol 146: 227-236.
16. De Bleecker J, Willems J, Van Den Neucker K, De Reuck J, Vogelaers D (1992) Prolonged toxicity with intermediate syndrome after combined parathion and methyl parathion poisoning. J Toxicol Clin Toxicol 30: 333-345; discussion 347-349.
17. De Bleecker J, Van Den Neucker K, Willems J (1992) The intermediate syndrome in organophosphate poisoning: presentation of a case and review of the literature. J Toxicol Clin Toxicol 30: 321-329; discussion 331-332.
18. De Bleecker J, Volgelaers D, Ceutericl C, Van Den Neucker K, Williems J, et al. (1992) Intermediate syndrome due to prolonged parathion poisoning. Acta Neurologica Scand 86: 421-424.
19. De Bleecker JL (1993) Intermediate syndrome: prolonged cholinesterase inhibition. J Toxicol Clin Toxicol 31: 197-199.
20. De Bleecker JL (1996) Multiple system organ failure: link to intermediate syndrome indirect. J Toxicol Clin Toxicol 34: 249-250.
21. De Bleecker J, Lison D, Van Den Abeele K, Willems J, De Reuck J (1994) Acute and subacute organophosphate poisoning in the rat. Neurotoxicology 15: 341-348.
22. Besser R, Gutman L, Weilemann LS (1989) Inactivation of end-plate acetylcholinesterase during the course of organophosphate intoxications. Arch Toxicol 63: 412-415.
23. Maselli RA, Soliven BC (1991) Analysis of the organophosphate-induced electromyographic response to repetitive nerve stimulation: paradoxical response to edrophonium and D-tubocurarine. Muscle Nerve 14: 1182-1188.
24. Besser R, Gutmann L, Dillmann U, Weilemann LS, Hopf HC (1989) End-plate dysfunction in acute organophosphate intoxication. Neurology 39: 561-567.
25. Besser R, Gutmann L (1995) A quantitative study of the pancuronium antagonism at the motor endplate in human organophosphorus intoxication. Muscle Nerve 18: 956-960.
26. Singh G, Sidhu UP, Mahajan R, Avasthi G, Whig J (2000) Phrenic nerve conduction studies in acute organophosphate poisoning. Muscle Nerve 23: 627-632.
27. Besser R, Vogt T, Gutmann L (1990) Pancuronium improves the neuromuscular transmission defect of human organophosphate intoxication. Neurology 40: 1275-1277.
28. De Bleecker J, Van den Abeele K, De Reuck J (1994) Electromyography in relation to end-plate acetylcholinesterase in rats poisoned by different organophosphates. Neurotoxicology 15: 331-340.
29. Dongren Y, Tao L, Fengsheng H (1999) Electroneurophysiological studies in rats of acute dimethoate poisoning. Toxicol Lett 107: 249-254.
30. Maselli RA, Leung C (1993) Analysis of anticholinesterase-induced neuromuscular transmission failure. Muscle Nerve 16: 548-553.
31. Besser R, Vogt T, Gutmann L, Hopf HC, Wessler I (1992) Impaired neuromuscular transmission during partial inhibition of acetylcholinesterase: the role of stimulus-induced antidromic backfiring in the generation of the decrement-increment phenomenon. Muscle Nerve 15: 1072-1080.
32. Maselli RA, Leung C (1993) Analysis of neuromuscular transmission failure induced by anticholinesterases. Ann N Y Acad Sci 681: 402-404.
33. Eddleston M, Eyer P, Worek F, Mohamed F, Senarathna L, et al. (2005) Differences between organophosphorus insecticides in human self-poisoning: a prospective cohort study. Lancet 366: 1452-1459.
34. Worek F, Mast U, Kiderlen D, Diepold C, Eyer P (1999) Improved determination of acetylcholinesterase activity in human whole blood. Clin Chim Acta 288: 73-90.
35. Maselli R, Jacobsen JH, Spire JP (1986) Edrophonium: an aid in the diagnosis of acute organophosphate poisoning. Ann Neurol 19: 508-510.
36. Van den Neucker K, Vanderstraeten G, De Muynck M, De Wilde V (1991) The neurophysiologic examination in organophosphate ester poisoning. Case report and review of the literature. Electromyogr Clin Neurophysiol 31: 507-511.
37. Poojara L, Vasudevan D, Arun Kumar A, Kamat V (2003) Organophosphate poisoning: diagnosis of Intermediate syndrome. Indian J Crit Care 7: 94-102.
38. Sudakin DL, Mullins ME, Horowitz BZ, Abshier V, Letzig L (2000) Intermediate syndrome after malathion ingestion despite continuous infusion of pralidoxime. J Toxicol Clin Toxicol 38: 47-50.
39. de Silva HJ, Wijewickrema R, Senanayake N (1992) Does pralidoxime affect outcome of management in acute organophosphorus poisoning? Lancet 339: 1136-1138.
40. Karalliedde L, Baker D, Marrs TC (2006) Organophosphate-induced intermediate syndrome: aetiology and relationships with myopathy. Toxicol Rev 25: 1-14.
41. Martyn JA, White DA, Gronert GA, Jaffe RS, Ward JM (1992) Up-and-down regulation of skeletal muscle acetylcholine receptors. Effects on neuromuscular blockers. Anesthesiology 76: 822-843.
42. Mahadeva B, Phillips LH 2nd, Juel VC (2008) Autoimmune disorders of neuromuscular transmission. Semin Neurol 28: 212-227.
43. Eaton LM, Lambert EH (1957) Electromyography and electric stimulation of nerves in diseases of motor unit; observations on myasthenic syndrome associated with malignant tumors. J Am Med Assoc 163: 1117-1124.
44. Lambert EH (1966) Defects of neuromuscular transmission in syndromes other than myasthenia gravis. Ann N Y Acad Sci 135: 367-384.
45. Cherington M (2004) Botulism: update and review. Semin Neurol 24: 155-163.
46. Kohara N, Lin TS, Fukudome T, Kimura J, Sakamoto T, et al. (2002) Pathophysiology of weakness in a patient with congenital end-plate acetylcholinesterase deficiency. Muscle Nerve 25: 585-592.
47. Hutchinson DO, Walls TJ, Nakano S, Camp S, Taylor P, et al. (1993) Congenita] endplate acetylcholinesterase deficiency. Brain 116: 633-653.